November 10, 2023 BY Elizabeth Anderson
AstraZeneca’s Q3 financial report bodes profit growth
This is the third consecutive quarter that the company came in ahead of analyst predictions. Chief executive officer (CEO) of the Cambridge-based pharmaceutical enterprise, Pascal Soriot, said: Our company continued its strong growth trajectory in the third quarter with Total Revenue from our non-COVID-19 medicines up 13% compared to last year. To boost its future…
Read more